Drugs / Liposomal Cyclosporine A
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03657342 | Mar 2019 → Apr 2024 | chronic transplant rejection, transplant-related bronchiolitis obliterans | Zambon SpA | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liposomal Cyclosporine A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03657342 ↗ |
| Route | Inhaled | “This formulation is developed for inhalation use” NCT03657342 ↗ |